Trial results showing that a potent anti-obesity drug offers strong protection against serious heart problems have electrified researchers. They say that the findings could change how this and other ...

Injectable weight-loss drugs can reduce the risk of serious cardiovascular events for people with type 2 diabetes.

Using two types of cardiovascular drugs together could help to treat fatty liver disease and reduce the number of severe cases. This is the finding of researchers from the University of Barcelona (UB) ...

A new drug being trialed in heart attack patients could reprogram the immune system to prevent inflammation and heart damage following severe heart attacks, and promote repair. This could be a ...

Wegovy could be good for more than just weight loss — the once-weekly semaglutide shot has been shown to reduce the risk of heart attack and stroke. The popular obesity medication successfully ...

A new study assessing provincial and territorial variations in reimbursement criteria of drug coverage for patients covered by Canada's public pharmacare programs for two common cardiovascular ...

Some products of arachidonic acid have already been well studied: the prostanoids formed by cyclooxygenases are central ...

Heart disease patients with symptomatic COVID-19 are often treated with nirmatrelvir-ritonavir (Paxlovid) to prevent progression to severe disease; however, it can interact with some previously ...

The cardiovascular system consists of the heart, blood vessels, and blood. Its primary function is to transport nutrients and oxygen-rich blood to all parts of the body and to carry deoxygenated blood ...